Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
May 19, 2025May 22, 2025Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$0.67$7,177-3.38%
Feb 19, 2025Feb 21, 2025Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$1.01$10,403-3.15%
Dec 19, 2024Dec 21, 2024Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$0.94$48,048-13.52%
Nov 19, 2024Nov 21, 2024Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$1.01$7,863-3.10%
Aug 19, 2024Aug 21, 2024Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$1.28$8,788-2.66%
May 17, 2024May 21, 2024Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$1.75$12,871-2.78%
Feb 20, 2024Feb 23, 2024Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$0.68$6,130-3.29%
Nov 17, 2023Nov 21, 2023Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$0.49$4,727-3.40%
Aug 16, 2023Aug 18, 2023Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$0.78$7,568-3.31%
May 16, 2023May 18, 2023Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$0.72$7,050-3.23%
Feb 16, 2023Feb 18, 2023Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$3$31,452-3.34%
Nov 16, 2022Nov 18, 2022Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$3.57$48,052-4.11%
Aug 18, 2022Aug 19, 2022Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$4.65$342,779-18.39%
Aug 16, 2022Aug 17, 2022Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$4.76$50,266-2.57%
May 16, 2022May 18, 2022Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$3.95$85,608-7.27%
Feb 16, 2022Feb 18, 2022Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$10.95$119,486-3.83%
Nov 16, 2021Nov 17, 2021Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$13.16$274,636-8.25%
Aug 16, 2021Aug 18, 2021Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$13.83$105,965-3.48%
May 17, 2021May 19, 2021Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$18.3$569,331-11.69%
Feb 16, 2021Feb 19, 2021Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$22.37$540,034-8.32%
Nov 23, 2020Nov 25, 2020Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$16.4$268,632-6.14%
Nov 16, 2020Nov 19, 2020Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$16.93$501,433-10.00%
Aug 17, 2020Aug 19, 2020Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$19.67$515,354-8.12%
May 18, 2020May 20, 2020Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$22.51$102,601-1.39%
Feb 18, 2020Feb 20, 2020Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$22.35$106,699-1.44%
Nov 18, 2019Nov 21, 2019Zalevsky Jonathan
Chief R
D Officer
SellNektar TherapeuticsNKTR$17.97$71,161-1.34%